z-logo
open-access-imgOpen Access
Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma
Author(s) -
Yanwei Luo,
Xiaopeng Huang,
Jun Zhan,
Shuai Zhang
Publication year - 2021
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s337769
Subject(s) - nomogram , hepatocellular carcinoma , medicine , oncology , cohort , stage (stratigraphy) , biomarker , cirrhosis , cancer research , biology , paleontology , biochemistry
Due to the limitations of currently available biomarkers, new biomarkers are needed to accurately predict the prognosis of patients with hepatocellular carcinoma (HCC) patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here